PT  - JOURNAL ARTICLE
AU  - Woo, Sang H.
AU  - Rios-Diaz, Arturo J.
AU  - Kubey, Alan A.
AU  - Cheney-Peters, Dianna R.
AU  - Ackermann, Lily L.
AU  - Chalikonda, Divya M.
AU  - Venkataraman, Chantel M.
AU  - Riley, Joshua M.
AU  - Baram, Michael
TI  - Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model
AID  - 10.1101/2020.07.16.20155739
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.16.20155739
4099  - http://medrxiv.org/content/early/2020/07/18/2020.07.16.20155739.short
4100  - http://medrxiv.org/content/early/2020/07/18/2020.07.16.20155739.full
AB  - Background Coronavirus disease 2019 (COVID-19) carries high morbidity and mortality globally. Identification of patients at risk for clinical deterioration upon presentation would aid in triaging, prognostication, and allocation of resources and experimental treatments.Research Question Can we develop and validate a web-based risk prediction model for identification of patients who may develop severe COVID-19, defined as intensive care unit (ICU) admission, mechanical ventilation, and/or death?Methods This retrospective cohort study reviewed 415 patients admitted to a large urban academic medical center and community hospitals. Covariates included demographic, clinical, and laboratory data. The independent association of predictors with severe COVID-19 was determined using multivariable logistic regression. A derivation cohort (n=311, 75%) was used to develop the prediction models. The models were tested by a validation cohort (n=104, 25%).Results The median age was 66 years (Interquartile range [IQR] 54-77) and the majority were male (55%) and non-White (65.8%). The 14-day severe COVID-19 rate was 39.3%; 31.7% required ICU, 24.6% mechanical ventilation, and 21.2% died. Machine learning algorithms and clinical judgment were used to improve model performance and clinical utility, resulting in the selection of eight predictors: age, sex, dyspnea, diabetes mellitus, troponin, C-reactive protein, D-dimer, and aspartate aminotransferase. The discriminative ability was excellent for both the severe COVID-19 (training area under the curve [AUC]=0.82, validation AUC=0.82) and mortality (training AUC= 0.85, validation AUC=0.81) models. These models were incorporated into a mobile-friendly website.Interpretation This web-based risk prediction model can be used at the bedside for prediction of severe COVID-19 using data mostly available at the time of presentation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding for this manuscriptAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Thomas Jefferson University Institutional Review Board approved this study and waived informed consent from study participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available